计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| A128022-1mg |
1mg |
现货 ![]() |
| |
| A128022-5mg |
5mg |
现货 ![]() |
| |
| A128022-25mg |
25mg |
现货 ![]() |
| |
| A128022-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | F6O | SMR004702945 | UNII-HP4L6MXF10 | XTB91715 | NCGC00345791-01 | N2-(2-(isopropylsulfonyl)phenyl)-N4-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-1,3,5-triazine-2,4-diamine | CCG-270132 | NSC765865 | NSC-765865 | CHEBI:167650 | N(2)-[ |
|---|---|
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | ASP3026 |
| 生化机理 | 有力的间变性淋巴瘤激酶(ALK)抑制剂(IC50 = 3.5 nM)。还抑制Ack和ROS1活性(IC50值分别为5.8和8.9 nM)。在体外减弱NPM-ALK + T细胞间变性大细胞淋巴瘤(ALCL)细胞的增殖并诱导其凋亡。抑制小鼠中NPM-ALK + ALCL细胞异种移植物的肿瘤生长。在hEML4-ALK转基因小鼠中引起肿瘤缩小。口服。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | ALK 酪氨酸激酶受体抑制剂 |
| 产品介绍 |
ASP3026是高活性ALK抑制剂,IC50为3.5 nM。 ASP3026 is a novel and selective inhibitor for ALK with IC50 of 3.5 nM. |
| 纯度 | ≥98% |
| ALogP | 4.8 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
| INCHI | 1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
| InChi Key | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
| Smiles | CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC |
| Isomeric SMILES | CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC |
| 分子量 | 580.74 |
| Reaxy-Rn | 20102809 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=20102809&ln= |
| 溶解性 | 溶于DMSO, 最高浓度 (mg/mL): 11.61, 最高浓度(mM): 20 |
|---|---|
| 分子量 | 580.700 g/mol |
| XLogP3 | 4.800 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 11 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 580.294 Da |
| 单同位素质量Monoisotopic Mass | 580.294 Da |
| 拓扑极表面积Topological Polar Surface Area | 124.000 Ų |
| 重原子数Heavy Atom Count | 41 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 904.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Mori M, Ueno Y, Konagai S, Fushiki H, Shimada I, Kondoh Y, Saito R, Mori K, Shindou N, Soga T et al.. (2014) The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice.. Mol Cancer Ther, 13 (2): (329-40). [PMID:24419060] |
| 2. George SK, Vishwamitra D, Manshouri R, Shi P, Amin HM. (2014) The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.. Oncotarget, 5 (14): (5750-63). [PMID:25026277] |